Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials - PubMed (original) (raw)

Review

Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials

Shira Zelber-Sagi et al. Therap Adv Gastroenterol. 2016 May.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is emerging as a major public health problem because of its association with increased cardiovascular and liver-related morbidity and mortality. Both genetic factors and lifestyle contribute to the pathogenesis of NAFLD. Lifestyle, including dietary habits and physical activity, is a modifiable risk factor and thus represents the main target for the prevention and treatment of NAFLD. In this review, we summarize the evidence regarding nutritional aspects (i.e. total energy intake, saturated fat and carbohydrates intake, certain foods or drinks and dietary patterns as a whole) in the treatment of NAFLD. In addition, we analyze the evidence concerning the independent effect of physical activity, including aerobic and resistance training, in the treatment of NAFLD. A therapeutic algorithm according to results from intervention trials is also provided for clinicians and other healthcare professionals involved in the management of NAFLD.

Keywords: coffee; diet; lifestyle; nonalcoholic fatty liver disease; physical activity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.

Figures

Figure 1.

Figure 1.

Algorithm for lifestyle changes in nonalcoholic fatty liver disease (NAFLD). MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.

References

    1. Abdelmalek M., Suzuki A., Guy C., Unalp-Arida A., Colvin R., Johnson R., et al. (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51: 1961–1971. - PMC - PubMed
    1. Abid A., Taha O., Nseir W., Farah R., Grosovski M., Assy N. (2009) Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 51: 918–924. - PubMed
    1. Afzali A., Weiss N., Boyko E., Ioannou G. (2010) Association between serum uric acid level and chronic liver disease in the United States. Hepatology 52: 578–589. - PubMed
    1. Andersen T., Gluud C., Franzmann M., Christoffersen P. (1991) Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12: 224–229. - PubMed
    1. Anty R., Marjoux S., Iannelli A., Patouraux S., Schneck A., Bonnafous S., et al. (2012) Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 57: 1090–1096. - PubMed

Publication types

LinkOut - more resources